DK2170287T3 - Mikropartikler omfattende PCL og anvendelser deraf - Google Patents
Mikropartikler omfattende PCL og anvendelser derafInfo
- Publication number
- DK2170287T3 DK2170287T3 DK08779052.3T DK08779052T DK2170287T3 DK 2170287 T3 DK2170287 T3 DK 2170287T3 DK 08779052 T DK08779052 T DK 08779052T DK 2170287 T3 DK2170287 T3 DK 2170287T3
- Authority
- DK
- Denmark
- Prior art keywords
- pcl
- microparticles
- applications
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/025—Explicitly spheroidal or spherical shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/85—Polyesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/654—The particulate/core comprising macromolecular material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95205607P | 2007-07-26 | 2007-07-26 | |
EP07113251 | 2007-07-26 | ||
PCT/NL2008/050506 WO2009014441A2 (en) | 2007-07-26 | 2008-07-23 | Microparticles comprising pcl and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2170287T3 true DK2170287T3 (da) | 2014-02-10 |
Family
ID=38924473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08779052.3T DK2170287T3 (da) | 2007-07-26 | 2008-07-23 | Mikropartikler omfattende PCL og anvendelser deraf |
Country Status (18)
Country | Link |
---|---|
US (3) | US8795694B2 (da) |
EP (1) | EP2170287B1 (da) |
JP (2) | JP5723152B2 (da) |
KR (1) | KR101517256B1 (da) |
CN (2) | CN101842084B (da) |
AU (1) | AU2008279879B2 (da) |
BR (1) | BRPI0814319A2 (da) |
CA (1) | CA2694852C (da) |
DK (1) | DK2170287T3 (da) |
ES (1) | ES2443537T3 (da) |
IL (2) | IL203536A (da) |
MX (1) | MX2010000953A (da) |
NZ (1) | NZ582813A (da) |
PL (1) | PL2170287T3 (da) |
PT (1) | PT2170287E (da) |
SI (1) | SI2170287T1 (da) |
UA (1) | UA97988C2 (da) |
WO (1) | WO2009014441A2 (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2010000953A (es) * | 2007-07-26 | 2010-07-06 | Aqtis Ip Bv | Microparticulas que comprenden pcl y uso de las misas. |
RU2012107812A (ru) * | 2009-08-05 | 2013-09-10 | Аллерган, Инк. | Препараты мутеинов липокалинов с контролируемым высвобождением |
WO2017014431A1 (ko) * | 2015-07-17 | 2017-01-26 | (주)인벤티지랩 | 생분해성 고분자를 포함하는 마이크로파티클의 제조방법 |
KR101726559B1 (ko) * | 2015-07-17 | 2017-04-26 | (주)인벤티지랩 | 생분해성 고분자를 포함하는 마이크로파티클의 제조방법 |
WO2018110792A1 (ko) * | 2016-12-13 | 2018-06-21 | 주식회사 삼양바이오팜 | 생분해성 고분자의 다공성 미립자, 및 이를 포함하는 고분자 필러 |
KR101942449B1 (ko) | 2016-12-13 | 2019-01-28 | 주식회사 삼양바이오팜 | 생분해성 고분자의 다공성 미립자, 및 이를 포함하는 고분자 필러 |
KR20180131478A (ko) | 2017-05-30 | 2018-12-10 | 에이큐파 아이피 비.브이. | 신규한 재흡수 생분해성 의약 및 화장료 조성물 |
RU2660550C1 (ru) * | 2017-06-28 | 2018-07-06 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации | Способ получения инъекционного резорбируемого имплантата на основе поликапролактона и мультипотентных стромальных клеток пупочного канатика |
RU2749803C1 (ru) * | 2018-01-10 | 2021-06-17 | Джи2Джибио, Инк. | Поликапролактоновый микросферный филлер, содержащий коллагеновый пептид, и способ его изготовления |
CN111836654B (zh) * | 2018-01-10 | 2022-11-15 | G2G生物公司 | 含维生素c的聚己内酯微球填充物及其制备方法 |
CN110339397B (zh) * | 2019-07-11 | 2021-12-21 | 山东省药学科学院 | 一种不含助悬剂的可注射皮肤填充剂及其制备方法和用途 |
CN110279887B (zh) * | 2019-07-18 | 2021-12-14 | 王月玲 | 一种多用途光子冷凝胶及其制备方法 |
CN110327497A (zh) * | 2019-07-31 | 2019-10-15 | 易浦润(上海)生物技术有限公司 | 一种含微球的注射用凝胶及其制备方法 |
KR102381291B1 (ko) | 2019-10-08 | 2022-04-01 | 주식회사 메타바이오메드 | 폴리디옥사논계 필러용 미립구의 제조방법 |
CN111184909B (zh) * | 2019-10-21 | 2022-08-09 | 湖北翎美生物科技有限公司 | 一种透明质酸缓释填充物及制备方法 |
CN111249524B (zh) * | 2020-01-18 | 2020-12-08 | 南京医科大学附属口腔医院 | 用于骨组织再生的高孔隙率聚己内酯多孔微球支架及其制备方法 |
US11684874B2 (en) | 2020-12-29 | 2023-06-27 | Metal Industries Research & Development Centre | Tangential flow filtration module and tangential flow filtration assembly |
US20230053336A1 (en) * | 2021-08-19 | 2023-02-23 | Jabil Inc. | Nucleation method of producing polycaprolactone powder |
CN113694252A (zh) * | 2021-08-30 | 2021-11-26 | 济南大学 | 一种软组织充填剂的聚己内酯微球及其制备方法 |
CN114146220B (zh) * | 2022-02-10 | 2022-04-29 | 中国远大集团有限责任公司 | 一种包含无菌pcl微球的美容产品 |
CN115282337B (zh) * | 2022-09-30 | 2023-01-17 | 中国远大集团有限责任公司 | 一种聚己内酯微球预分散组合物及由其制备的聚己内酯注射用凝胶 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07196479A (ja) * | 1994-01-04 | 1995-08-01 | Unitika Ltd | マイクロカプセルの製造法 |
US5599852A (en) | 1994-10-18 | 1997-02-04 | Ethicon, Inc. | Injectable microdispersions for soft tissue repair and augmentation |
US20030157187A1 (en) * | 1996-12-02 | 2003-08-21 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for treating or preventing inflammatory diseases |
US6515016B2 (en) * | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
FR2764514B1 (fr) | 1997-06-13 | 1999-09-03 | Biopharmex Holding Sa | Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique |
US6495164B1 (en) * | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
WO2002058671A1 (en) * | 2001-01-26 | 2002-08-01 | Debio Recherche Pharmaceutique S.A. | Burst free pharmaceutical microparticules |
ES2385030T3 (es) | 2001-06-29 | 2012-07-17 | Medgraft Microtech, Inc. | Implantes inyectables biodegradables y procedimientos relacionados con su fabricación y uso |
KR20030077386A (ko) * | 2002-03-25 | 2003-10-01 | 주식회사 큐리안 | 생분해성 중합체 미립구의 신규 치료용도 |
NL1021843C2 (nl) | 2002-11-05 | 2004-05-07 | Univ Twente | Biomedische structuren van poly (1,3-trimethyleencarbonaat) (poly (TMC)). |
CN101027065A (zh) | 2004-06-15 | 2007-08-29 | 陈献 | 磷脂组合物及其制备和使用方法 |
EP2012751A4 (en) * | 2006-03-21 | 2010-11-24 | Morehouse School Of Medicine | NEW NANOPARTICLES FOR THE DELIVERY OF ACTIVE AGENTS |
US9119902B2 (en) * | 2006-06-22 | 2015-09-01 | Ethicon, Inc. | Semi-crystalline absorbable microspheres |
MX2009003661A (es) * | 2006-10-06 | 2009-04-22 | Baxter Int | Microcapsulas que contienen microparticulas modificadas en la superficie y metodos para formar y utilizar las mismas. |
MX2010000953A (es) * | 2007-07-26 | 2010-07-06 | Aqtis Ip Bv | Microparticulas que comprenden pcl y uso de las misas. |
-
2008
- 2008-07-23 MX MX2010000953A patent/MX2010000953A/es unknown
- 2008-07-23 KR KR1020107004604A patent/KR101517256B1/ko active IP Right Grant
- 2008-07-23 AU AU2008279879A patent/AU2008279879B2/en active Active
- 2008-07-23 ES ES08779052.3T patent/ES2443537T3/es active Active
- 2008-07-23 NZ NZ582813A patent/NZ582813A/en unknown
- 2008-07-23 CN CN200880104393.3A patent/CN101842084B/zh active Active
- 2008-07-23 US US12/670,518 patent/US8795694B2/en active Active
- 2008-07-23 PL PL08779052T patent/PL2170287T3/pl unknown
- 2008-07-23 UA UAA201000720A patent/UA97988C2/ru unknown
- 2008-07-23 SI SI200831134T patent/SI2170287T1/sl unknown
- 2008-07-23 WO PCT/NL2008/050506 patent/WO2009014441A2/en active Application Filing
- 2008-07-23 PT PT87790523T patent/PT2170287E/pt unknown
- 2008-07-23 BR BRPI0814319A patent/BRPI0814319A2/pt not_active Application Discontinuation
- 2008-07-23 EP EP08779052.3A patent/EP2170287B1/en active Active
- 2008-07-23 CN CN201410177510.6A patent/CN104001209B/zh active Active
- 2008-07-23 JP JP2010518139A patent/JP5723152B2/ja active Active
- 2008-07-23 CA CA2694852A patent/CA2694852C/en active Active
- 2008-07-23 DK DK08779052.3T patent/DK2170287T3/da active
-
2010
- 2010-01-26 IL IL203536A patent/IL203536A/en active IP Right Grant
-
2014
- 2014-07-01 US US14/321,392 patent/US20150004206A1/en not_active Abandoned
- 2014-07-08 IL IL233562A patent/IL233562A0/en unknown
- 2014-12-26 JP JP2014266531A patent/JP5965472B2/ja active Active
-
2021
- 2021-12-14 US US17/549,894 patent/US20220105038A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BRPI0814319A2 (pt) | 2017-05-23 |
PL2170287T3 (pl) | 2014-04-30 |
EP2170287B1 (en) | 2013-11-06 |
NZ582813A (en) | 2011-09-30 |
CN104001209A (zh) | 2014-08-27 |
JP5965472B2 (ja) | 2016-08-03 |
JP2010534649A (ja) | 2010-11-11 |
PT2170287E (pt) | 2014-02-14 |
JP2015110595A (ja) | 2015-06-18 |
KR101517256B1 (ko) | 2015-05-07 |
MX2010000953A (es) | 2010-07-06 |
SI2170287T1 (sl) | 2014-04-30 |
WO2009014441A2 (en) | 2009-01-29 |
CA2694852C (en) | 2017-02-28 |
IL203536A (en) | 2014-07-31 |
US20150004206A1 (en) | 2015-01-01 |
US20220105038A1 (en) | 2022-04-07 |
CN104001209B (zh) | 2017-04-12 |
IL233562A0 (en) | 2014-08-31 |
US20100215702A1 (en) | 2010-08-26 |
WO2009014441A3 (en) | 2009-04-23 |
CN101842084A (zh) | 2010-09-22 |
AU2008279879A2 (en) | 2010-02-18 |
CA2694852A1 (en) | 2009-01-29 |
KR20100065309A (ko) | 2010-06-16 |
CN101842084B (zh) | 2014-11-05 |
AU2008279879B2 (en) | 2014-02-13 |
ES2443537T3 (es) | 2014-02-19 |
AU2008279879A1 (en) | 2009-01-29 |
EP2170287A2 (en) | 2010-04-07 |
UA97988C2 (en) | 2012-04-10 |
US8795694B2 (en) | 2014-08-05 |
JP5723152B2 (ja) | 2015-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2170287T3 (da) | Mikropartikler omfattende PCL og anvendelser deraf | |
NL350099I2 (nl) | Benzovindiflupyr en Difenoconazole | |
DK3292874T3 (da) | Anti-mesothelin-immunkonjugater og anvendelser deraf | |
DK2281006T3 (da) | Tværbindingsmidler og anvendelser deraf | |
CY2015013I2 (el) | Αντι-μολυσματικες πυραμιδινες και χρησεις αυτων | |
DK2209806T3 (da) | Anti-hepcidin-antistoffer og anvendelser deraf | |
DK2139490T3 (da) | Diazo-bicykliske smac-mimetiske stoffer og anvendelser deraf | |
DK2142529T3 (da) | Trpv1-antagonister og anvendelser deraf | |
DK2170827T3 (da) | Indolin-2-oner og aza-indolin-2-oner | |
BRPI0812367A2 (pt) | Dispositivos interoclusais e respectivos métodos de fabrico | |
BRPI0907231A2 (pt) | pirrolpirimidinas e pirrolpiridinas | |
DK2068887T3 (da) | SP35-antistoffer og anvendelser heraf | |
DK2012773T3 (da) | Lægemidler og anvendelser deraf | |
BRPI0807225A2 (pt) | Dispositivo e método endocirúrgico | |
DK2059535T3 (da) | Prlr-specifikt antistof og anvendelser deraf | |
DK3338790T3 (da) | Oligopeptid-forbindelser og anvendelser deraf | |
DK2913344T3 (da) | Specifikke bindingsproteiner og anvendelser deraf | |
DK2185552T3 (da) | Dipeptoid-prodrugs og anvendelse heraf | |
BRPI0816907A2 (pt) | Método e dispositivo | |
DK2310356T3 (da) | Adamantyl-diamid-derivater og anvendelser deraf | |
DK2245032T3 (da) | Folater, sammensætninger og anvendelser deraf | |
DK2352509T3 (da) | Hla-g-proteiner og farmaceutiske anvendelser deraf | |
DK2328931T3 (da) | Selektive anti-hepcidin-25-antistoffer og anvendelser deraf | |
DK2086213T3 (da) | Billedlæseapparat og billeddannelseapparat | |
DE602006015540D1 (de) | Durchführung und buchse |